COO of Krystal Biotech Inc (30-Year Financial, Insider Trades) Suma Krishnan (insider trades) sold 50,000 shares of KRYS on 06/15/2020 at an average price of $43.5 a share. The total sale was $2.2 million.
Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders. Krystal Biotech Inc has a market cap of $898.490 million; its shares were traded at around $45.70 . GuruFocus has detected 1 severe warning sign with Krystal Biotech Inc. .
Directors and Officers Recent Trades:
- COO, 10% Owner Suma Krishnan sold 50,000 shares of KRYS stock on 06/15/2020 at the average price of $43.5. The price of the stock has increased by 5.06% since.
For the complete insider trading history of KRYS, click here
.